Thomas Keane to Biomarkers, Tumor
This is a "connection" page, showing publications Thomas Keane has written about Biomarkers, Tumor.
Connection Strength
0.318
-
Salvage options for biochemical recurrence after primary therapy for prostate cancer. Can J Urol. 2007 Dec; 14 Suppl 1:2-9.
Score: 0.228
-
Selective estrogen receptor alpha agonist GTx-758 decreases testosterone with reduced side effects of androgen deprivation therapy in men with advanced prostate cancer. Eur Urol. 2015 Feb; 67(2):334-41.
Score: 0.090